secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIPELLA PHARMACEUTICALS INC. (LIPO)
CIK:        0001347242
Form:       8-K
Filed at:   2024-11-07T23:59:59+00:00
Accession:  0001753926-24-001824
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lipella Pharmaceuticals effects 1-for-8 reverse stock split
-----------------------------------------------------------

- Reverse split effective Nov 7, 2024; every 8 shares converted to 1 share.
- No fractional shares issued; holders paid cash for fractional interests.
- Authorized share count unchanged; options and warrants adjusted proportionally.
- Common stock trades split-adjusted on Nasdaq Capital Market starting Nov 8.
- New CUSIP number for common stock is 53630L 209.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347242/000175392624001824/0001753926-24-001824-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347242/000175392624001824/g084539_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-24-001824

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer